317 related articles for article (PubMed ID: 20228028)
1. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
2. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
4. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
5. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
6. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
Khameneh ZR; Baradaran M; Sepehrvand N
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
[TBL] [Abstract][Full Text] [Related]
7. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina].
Brun RO; Astarloa L; Salomon HE; Biglione MM
Medicina (B Aires); 2004; 64(2):125-8. PubMed ID: 15628298
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.
Barrientos A; Lopez M; Sotomayor C; Pilleux L; Calderón S; Navarrete M; Otth C
J Med Virol; 2011 Apr; 83(4):745-8. PubMed ID: 21328393
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
12. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
15. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588
[TBL] [Abstract][Full Text] [Related]
18. Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved.
Eirin ME; Berini CA; Jones LR; Dilernia DA; Puca AA; Biglione MM
J Med Virol; 2010 Dec; 82(12):2116-22. PubMed ID: 20981802
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Biglione MM; Astarloa L; Salomón HE;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
